Retinoic acid-loaded liposomes induce human mucosal CD103 ⁺ dendritic cells that inhibit Th17 cells and drive regulatory T-cell development in vitro.

Autor: Nagy NA; Department of Experimental Immunology, Amsterdam University Medical Centers, Amsterdam Institute for Infection & Immunity, University of Amsterdam, Amsterdam, The Netherlands., Hafkamp FMJ; Department of Experimental Immunology, Amsterdam University Medical Centers, Amsterdam Institute for Infection & Immunity, University of Amsterdam, Amsterdam, The Netherlands., Sparrius R; Department of Experimental Immunology, Amsterdam University Medical Centers, Amsterdam Institute for Infection & Immunity, University of Amsterdam, Amsterdam, The Netherlands., Bas R; Department of Experimental Immunology, Amsterdam University Medical Centers, Amsterdam Institute for Infection & Immunity, University of Amsterdam, Amsterdam, The Netherlands., Lozano Vigario F; Division of BioTherapeutics, Leiden Academic Center for Drug Research, Leiden, The Netherlands., van Capel TMM; Department of Experimental Immunology, Amsterdam University Medical Centers, Amsterdam Institute for Infection & Immunity, University of Amsterdam, Amsterdam, The Netherlands., van Ree R; Department of Experimental Immunology, Amsterdam University Medical Centers, Amsterdam Institute for Infection & Immunity, University of Amsterdam, Amsterdam, The Netherlands.; Department of Otorhinolaryngology, Amsterdam University Medical Centers, Amsterdam, The Netherlands., Geijtenbeek TBH; Department of Experimental Immunology, Amsterdam University Medical Centers, Amsterdam Institute for Infection & Immunity, University of Amsterdam, Amsterdam, The Netherlands., Slütter B; Division of BioTherapeutics, Leiden Academic Center for Drug Research, Leiden, The Netherlands., Tas SW; Department of Experimental Immunology, Amsterdam University Medical Centers, Amsterdam Institute for Infection & Immunity, University of Amsterdam, Amsterdam, The Netherlands.; Department of Rheumatology and Clinical Immunology, Amsterdam University Medical Centers, Amsterdam Rheumatology and Immunology Center, Amsterdam, The Netherlands., de Jong EC; Department of Experimental Immunology, Amsterdam University Medical Centers, Amsterdam Institute for Infection & Immunity, University of Amsterdam, Amsterdam, The Netherlands.

Publikováno v: European journal of immunology [Eur J Immunol] 2024 May; Vol. 54 (5), pp. e2350839. Date of Electronic Publication: 2024 Mar 02.

Aberrant neutrophil degranulation in hospitalized patients with COVID-19 partially remains for 6 months.

Autor: Hafkamp FMJ; Department of Experimental Immunology, Amsterdam University Medical Center, University of Amsterdam, Amsterdam, the Netherlands.; Amsterdam Institute for Infection and Immunity, Amsterdam, the Netherlands., Taanman-Kueter EWM; Department of Experimental Immunology, Amsterdam University Medical Center, University of Amsterdam, Amsterdam, the Netherlands.; Amsterdam Institute for Infection and Immunity, Amsterdam, the Netherlands., van Capel TMM; Department of Experimental Immunology, Amsterdam University Medical Center, University of Amsterdam, Amsterdam, the Netherlands.; Amsterdam Institute for Infection and Immunity, Amsterdam, the Netherlands., Wynberg E; Amsterdam Institute for Infection and Immunity, Amsterdam, the Netherlands.; Department of Infectious Diseases, Public Health Service of Amsterdam, Amsterdam, the Netherlands.; Department of Infectious Diseases, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands., van Willigen HDG; Amsterdam Institute for Infection and Immunity, Amsterdam, the Netherlands.; Department of Infectious Diseases, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands.; Department of Medical Microbiology & Infection Prevention, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands., Verveen A; Department of Medical Psychology, Amsterdam UMC, Amsterdam Public Health Research Institute, University of Amsterdam, Amsterdam, the Netherlands., Kootstra NA; Department of Experimental Immunology, Amsterdam University Medical Center, University of Amsterdam, Amsterdam, the Netherlands.; Amsterdam Institute for Infection and Immunity, Amsterdam, the Netherlands., Nieuwkerk P; Department of Medical Psychology, Amsterdam UMC, Amsterdam Public Health Research Institute, University of Amsterdam, Amsterdam, the Netherlands., de Jong MD; Amsterdam Institute for Infection and Immunity, Amsterdam, the Netherlands.; Department of Medical Microbiology & Infection Prevention, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands., de Bree GJ; Amsterdam Institute for Infection and Immunity, Amsterdam, the Netherlands.; Department of Infectious Diseases, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands., Prins M; Amsterdam Institute for Infection and Immunity, Amsterdam, the Netherlands.; Department of Infectious Diseases, Public Health Service of Amsterdam, Amsterdam, the Netherlands.; Department of Infectious Diseases, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands., Hazenberg MD; Department of Experimental Immunology, Amsterdam University Medical Center, University of Amsterdam, Amsterdam, the Netherlands.; Amsterdam Institute for Infection and Immunity, Amsterdam, the Netherlands.; Department of Hematology, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands.; Department of Hematopoiesis, Sanquin Research, Amsterdam, the Netherlands., Groot Kormelink T; Department of Experimental Immunology, Amsterdam University Medical Center, University of Amsterdam, Amsterdam, the Netherlands.; Amsterdam Institute for Infection and Immunity, Amsterdam, the Netherlands., de Jong EC; Department of Experimental Immunology, Amsterdam University Medical Center, University of Amsterdam, Amsterdam, the Netherlands.; Amsterdam Institute for Infection and Immunity, Amsterdam, the Netherlands.

Publikováno v: European journal of immunology [Eur J Immunol] 2024 Jan; Vol. 54 (1), pp. e2350404. Date of Electronic Publication: 2023 Oct 30.

A novel peanut allergy immunotherapy: Plant-based enveloped Ara h 2 Bioparticles activate dendritic cells and polarize T cell responses to Th1.

Autor: Castenmiller C; Department of Experimental Immunology, Amsterdam University Medical Centers, Amsterdam Institute for Infection & Immunity, University of Amsterdam, Amsterdam, the Netherlands., Nagy NA; Department of Experimental Immunology, Amsterdam University Medical Centers, Amsterdam Institute for Infection & Immunity, University of Amsterdam, Amsterdam, the Netherlands., Kroon PZ; Department of Experimental Immunology, Amsterdam University Medical Centers, Amsterdam Institute for Infection & Immunity, University of Amsterdam, Amsterdam, the Netherlands., Auger L; Angany Inc., Québec, Canada., Desgagnés R; Angany Inc., Québec, Canada., Martel C; Angany Inc., Québec, Canada., Mirande L; Angany Innovation, Val-de-Reuil, France., Morel B; Angany Innovation, Val-de-Reuil, France., Roberge J; Angany Inc., Québec, Canada., Stordeur V; Angany Innovation, Val-de-Reuil, France., Tropper G; Angany Inc., Québec, Canada., Vézina LP; Angany Inc., Québec, Canada., van Ree R; Department of Experimental Immunology, Amsterdam University Medical Centers, Amsterdam Institute for Infection & Immunity, University of Amsterdam, Amsterdam, the Netherlands.; Department of Otorhinolaryngology, Amsterdam University Medical Centers, Amsterdam, the Netherlands., Gomord V; Angany Innovation, Val-de-Reuil, France., de Jong EC; Department of Experimental Immunology, Amsterdam University Medical Centers, Amsterdam Institute for Infection & Immunity, University of Amsterdam, Amsterdam, the Netherlands.

Publikováno v: The World Allergy Organization journal [World Allergy Organ J] 2023 Nov 10; Vol. 16 (11), pp. 100839. Date of Electronic Publication: 2023 Nov 10 (Print Publication: 2023).

Inflammatory and tolerogenic myeloid cells determine outcome following human allergen challenge.

Autor: Voskamp AL; Department of Parasitology, Leiden University Medical Center, Leiden, Netherlands., Tak T; Department of Parasitology, Leiden University Medical Center, Leiden, Netherlands., Gerdes ML; Department of Ear, Nose and Throat, Erasmus University Medical Center, Rotterdam, Netherlands., Menafra R; Leiden Genome Technology Center, Leiden University Medical Center , Leiden, Netherlands., Duijster E; Department of Internal Medicine, Section Allergology and Clinical Immunology, Erasmus University Medical Center , Rotterdam, Netherlands., Jochems SP; Department of Parasitology, Leiden University Medical Center, Leiden, Netherlands., Kielbasa SM; Department of Biomedical Data Sciences, Leiden University Medical Center, Leiden, Netherlands., Kormelink TG; Department of Exp Immunology, Amsterdam University Medical Centers, Amsterdam, Netherlands., Stam KA; Department of Parasitology, Leiden University Medical Center, Leiden, Netherlands., van Hengel ORJ; Department of Parasitology, Leiden University Medical Center, Leiden, Netherlands., de Jong NW; Department of Internal Medicine, Section Allergology and Clinical Immunology, Erasmus University Medical Center , Rotterdam, Netherlands., Hendriks RW; Department of Pulmonary Medicine, Erasmus University Medical Center, Rotterdam, Netherlands., Kloet SL; Leiden Genome Technology Center, Leiden University Medical Center , Leiden, Netherlands., Yazdanbakhsh M; Department of Parasitology, Leiden University Medical Center, Leiden, Netherlands., de Jong EC; Department of Exp Immunology, Amsterdam University Medical Centers, Amsterdam, Netherlands., Gerth van Wijk R; Department of Internal Medicine, Section Allergology and Clinical Immunology, Erasmus University Medical Center , Rotterdam, Netherlands., Smits HH; Department of Parasitology, Leiden University Medical Center, Leiden, Netherlands.

Publikováno v: The Journal of experimental medicine [J Exp Med] 2023 Sep 04; Vol. 220 (9). Date of Electronic Publication: 2023 Jul 10.

Glycan dependent phenotype differences of HIV-1 generated from macrophage versus CD4 ⁺ T helper cell populations.

Autor: Heeregrave EJ; Laboratory of Experimental Virology, Department of Medical Microbiology, Amsterdam University Medical Center, University of Amsterdam, Amsterdam, Netherlands., Thomas J; Department of Clinical Infection, Microbiology and Immunology, Institute of Veterinary and Ecological Sciences, University of Liverpool, Liverpool, United Kingdom., van Capel TM; Department of Experimental Immunology, University Medical Center, University of Amsterdam, Amsterdam, Netherlands., de Jong EC; Department of Experimental Immunology, University Medical Center, University of Amsterdam, Amsterdam, Netherlands., Pollakis G; Department of Experimental Immunology, University Medical Center, University of Amsterdam, Amsterdam, Netherlands., Paxton WA; Laboratory of Experimental Virology, Department of Medical Microbiology, Amsterdam University Medical Center, University of Amsterdam, Amsterdam, Netherlands.; Department of Clinical Infection, Microbiology and Immunology, Institute of Veterinary and Ecological Sciences, University of Liverpool, Liverpool, United Kingdom.

Publikováno v: Frontiers in immunology [Front Immunol] 2023 Jun 21; Vol. 14, pp. 1107349. Date of Electronic Publication: 2023 Jun 21 (Print Publication: 2023).